Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Sci. Aging Knowl. Environ., 17 July 2002
Vol. 2002, Issue 28, p. ns6
[DOI: 10.1126/sageke.2002.28.ns6]

NEWS SYNTHESIS

"Gero-Tech" Sprouts, But Will It Bloom?

Scientists hope to turn academic observations into marketable interventions

R. John Davenport, and Jennifer Toy

http://sageke.sciencemag.org/cgi/content/full/sageke;2002/28/ns6

Abstract: Companies are betting that studies of aging will reveal new routes to life-enhancing pharmaceuticals. Antiaging pills are a distant dream, in part because testing a drug for its effect on life-span is a practical impossibility and scientists haven't yet come up with a substitute measure of aging. But research on aging might yield novel ways to treat age-related disease. Along the way, private ventures are offering new resources and a variety of experiences to academic scientists.

Citation: R. J. Davenport, J. Toy, "Gero-Tech" Sprouts, But Will It Bloom? Science's SAGE KE (17 July 2002), http://sageke.sciencemag.org/cgi/content/full/sageke;2002/28/ns6

Read the Full Text

To Advertise     Find Products

Science of Aging Knowledge Environment. ISSN 1539-6150